John Butler

Track

Insider profile

Currently holds positions in Keryx Biopharmaceuticals Inc, Zynerba Pharmaceuticals Inc and Akebia Therapeutics Inc

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 82% 68% 82%
Transactions
14 7% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Keryx Biopharmaceuticals Inc Dec. 10, 2015 -
Independent Director Zynerba Pharmaceuticals Inc April 12, 2018 -
President, Chief Executive Officer, Director Akebia Therapeutics Inc Sept. 16, 2013 -
Independent Director Keryx Biopharmaceuticals Inc Dec. 10, 2015 - Dec. 12, 2018
Director Akebia Therapeutics Inc July 1, 2013 - Sept. 16, 2013
John Butler's trades of Akebia Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-05 2026-03-04
B Purchase
34,867 +35.9%
21.16
US$3,910,943 		34,867 +35.9% 21.16 US$3,910,943
2026-02-04 2026-02-02
PlS Planned sale
69,271 -4.2%
111.33
US$103,127 		69,271 -4.2% 111.33 US$103,127
2026-02-04 2026-02-02
PlS Planned sale
81,670 +10.8%
27.98
US$1,082,051 		81,670 +10.8% 27.98 US$1,082,051
2026-02-04 2026-02-02
PlS Planned sale
96,065 -2.8%
1.39
US$133,530 		96,065 -2.8% 1.39 US$133,530
2026-02-04 2026-02-02
PlS Planned sale
83,689 -2.5%
1.39
US$116,328 		83,689 -2.5% 1.39 US$116,328
2026-02-04 2026-02-02
PlS Planned sale
114,891 -3.5%
1.39
US$159,698 		114,891 -3.5% 1.39 US$159,698
2026-02-04 2026-02-02
PlS Planned sale
96,065 -2.8%
1.39
US$133,530 		96,065 -2.8% 1.39 US$133,530
2026-02-04 2026-02-02
PlS Planned sale
46,660 -1.3%
1.39
US$64,857 		46,660 -1.3% 1.39 US$64,857
2026-02-02 2026-02-02
PrS Proposed sale
341,305
1.39
US$475,950 		341,305 1.39 US$475,950
2025-03-04 2025-03-03
PlS Planned sale
46,409 -1.8%
1.83
US$84,928 		46,409 -1.8% 1.83 US$84,928
2025-03-03 2025-03-03
PrS Proposed sale
46,409
1.83
US$85,007 		46,409 1.83 US$85,007
2025-02-04 2025-02-03
PlS Planned sale
97,982 -3.6%
2.10
US$205,762 		97,982 -3.6% 2.10 US$205,762
2025-02-04 2025-02-03
PlS Planned sale
46,268 -1.7%
2.10
US$97,163 		46,268 -1.7% 2.10 US$97,163
2025-02-03 2025-02-03
PrS Proposed sale
144,250
2.10
US$303,589 		144,250 2.10 US$303,589
2024-03-01 2024-02-29
S Sale
46,570 -2.2%
1.58
US$73,581 		46,570 -2.2% 1.58 US$73,581
2024-02-29 2024-02-29
PrS Proposed sale
46,570
1.58
US$73,413 		46,570 1.58 US$73,413
2024-02-29 2024-02-27
S Sale
37,733 -1.8%
1.52
US$57,354 		37,733 -1.8% 1.52 US$57,354
2024-02-27 2024-02-27
PrS Proposed sale
37,733
1.52
US$57,252 		37,733 1.52 US$57,252
2024-02-02 2024-02-01
S Sale
46,489 -2.1%
1.68
US$78,102 		46,489 -2.1% 1.68 US$78,102
2024-02-01 2024-02-01
PrS Proposed sale
46,489
1.68
US$77,957 		46,489 1.68 US$77,957
2023-06-15 2023-06-14
S Sale
115 -0.1%
0.35
US$40 		115 -0.1% 0.35 US$40
2023-03-03 2023-03-01
S Sale
6,370 -0.4%
0.88
US$5,590 		6,370 -0.4% 0.88 US$5,590
2023-03-03 2023-03-01
S Sale
47,239 -2.9%
0.88
US$41,452 		47,239 -2.9% 0.88 US$41,452
2023-03-03 2023-03-01
S Sale
38,259 -2.3%
0.88
US$33,572 		38,259 -2.3% 0.88 US$33,572
2023-03-01 2023-02-27
S Sale
38,632 -2.3%
0.81
US$31,416 		38,632 -2.3% 0.81 US$31,416
2022-06-16 2022-06-14
S Sale
53 -0.2%
1.01
US$54 		53 -0.2% 1.01 US$54
2022-03-02 2022-03-01
S Sale
4,131 -0.3%
2.17
US$8,967 		4,131 -0.3% 2.17 US$8,967
2022-03-02 2022-03-01
S Sale
25,031 -1.7%
2.17
US$54,335 		25,031 -1.7% 2.17 US$54,335
2022-03-02 2022-03-01
S Sale
24,811 -1.7%
2.17
US$53,857 		24,811 -1.7% 2.17 US$53,857
2022-03-02 2022-02-28
PlS Planned sale
25,053 -2.1%
2.15
US$53,984 		25,053 -2.1% 2.15 US$53,984
2021-04-01 2021-04-01
S Sale
4,109 -0.4%
3.40
US$13,971 		4,109 -0.4% 3.40 US$13,971
2021-03-02 2021-03-01
S Sale
24,674 -2.2%
3.40
US$83,795 		24,674 -2.2% 3.40 US$83,795
2021-03-02 2021-03-01
S Sale
25,316 -2.2%
3.40
US$85,976 		25,316 -2.2% 3.40 US$85,976